Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

NCT01818648 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was withdrawn by PI due to decision to study a different medication.

Conditions

Short Bowel Syndrome

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

Mayo Clinic